Matthew Dawe: 40-Year-Old Man Diagnosed With Guillain-Barré Syndrome 11 Days After Receiving The AstraZeneca COVID-19 Vaccine

CALGARY, CANADA – A 40-year-old man has been diagnosed with Guillain-Barre syndrome just 11 days after receiving the AstraZeneca COVID-19 vaccine. Matthew Dawe received his shot on April 23rd and was hospitalized 10 days later with severe numbness and tingling in his body. A day later, a neurologist at the hospital diagnosed him with GBS.

Dawe was walking his dog about ten days after receiving the AstraZeneca vaccine when his feet went numb. Within hours, he was in the ER, slowly losing function in different parts of his body.

“My life is going to be invariably changed because of the decision to try and support the greater health of the community. And the relatively low probability of getting this, messes with your head a bit, right?

You don’t know where it’s going to stop.”